Save up -80% on Lumacaftor

Note: this is a drug discount program, not an insurance plan.

RX BIN: 015558
Group ID: DDN6600
Card Holder ID: DDN6600

Pharmacists and Patients support.

2018 Price of Lumacaftor


* price without discount in nearest pharmacy. Price may vary.

Claim your free Lumacaftor discount card

We offer free Lumacaftor coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Lumacaftor every time. What are you waiting for? Claim your prescription drug card now!

Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time

Lumacaftor volume of distribution

Following oral administration of 200 mg of lumacaftor every 24 hours to cystic fibrosis patients in a fed state for 28 days, the mean (+/-SD) for apparent volumes of distribution was 86.0 (69.8) L. (2)

About RX24Drugs

Discount Cards 16,000+

Clients Benefit 29%

Total savings $4,735,080

What is Lumacaftor

Lumacaftor is an experimental drug for the treatment of cystic fibrosis developed by Vertex Pharmaceuticals. The drug is designed to be effective in patients that have the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR), the defective protein that causes the disease. F508del, meaning that the amino acid phenylalanine in position 508 is missing, is found in about 60% of cystic fibrosis patients in Europe, and in about 90% of persons with some mutation in the CFTR gene.

Lumacaftor mechanism of action

The CFTR protein is a chloride channel and is found on the surface of epithelial cells in many tissues and organs. Cystic fibrosis involves an F508del mutation which results in a lower amount of properly processed chloride channels and also less which are successfully trafficked to cellular surfaces. Furthermore, the mutated CFTR that are able to reach cell surfaces will not function optimally. Lumacaftor helps stabilize F508del-CFTR, allowing more processing and trafficking to occur which increases the amount of mature protein that will reach cell surfaces. (2)

Dosage forms of Lumacaftor

Tablet, film coatedoral
Prescription Generics


International Brands



3-(6-{[1-(2,2-difluoro-2H-1,3-benzodioxol-5-yl)cyclopropane-1-carbonyl]amino}-3-methylpyridin-2-yl)benzoic acid lumacaftor


Vertex Pharmaceuticals (Canada) Incorporated

CAS number






Affected organisms

Indication of Lumacaftor

Cystic fibrosis is a disease that is caused by dysfunction of the ‘cystic fibrosis transmembrane conductance regulator protein’ (CFTR). As a result, cystic fibrosis affects many systems and involves progressive lung disease. Lumacaftor is an effective treatment for cystic fibrosis because it helps correct CFTR as well as the associated functions. (1)

Toxicity of Lumacaftor

Dyspnea, nasopharyngitis, nausea, diarrhea, upper respiratory tract infection, fatigue, respiration abnormal, blood creatine phosphokinase increased, rash, flatulence, rhinorrhea, and influenza are the most common adverse effects reported with the use of ORKAMBI. These adverse effects occurred in 5% of patients with cystic fibrosis homozygous for the F508del mutation in the CFTR gene. Lumacaftor is classified as Pregnancy Category B. (2)

RX24 Drugs Disclaimer: before buying a Lumacaftor on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.

Get lower price on Lumacaftor now!